BOSTON, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage

Medical sector earnings are off to a strong start, and four biotech companies are positioned to pote

Shares of Tango Therapeutics, Inc. (NASDAQ: TNGX - Get Free Report) have received an average rating

The average of price targets set by Wall Street analysts indicates a potential upside of 49.5% in Ta

Tango Therapeutics, Inc. (NASDAQ: TNGX - Get Free Report)'s share price shot up 6.1% on Friday. The

Mizuho analyst Joseph Catanzaro maintains Tango Therapeutics (NASDAQ:TNGX) with a Outperform and

Wall Street analysts initiated coverage on various top stocks, including VCYT, UMAC, FISN, LTRX, and

JP Morgan analyst Brian Cheng initiates coverage on Tango Therapeutics (NASDAQ:TNGX) with a Overw

Tango Therapeutics' strong 2026 rally reflects promising clinical progress, but its premium valuatio

TNGX is advancing precision oncology with MTAP-targeted therapies and 2026 data readouts that could

Tango Therapeutics enters a pivotal phase as vopimetostat drives its investment case, with 2026 clin

BOSTON, June 22, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage

BOSTON, June 09, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (“Tango”) (Nasdaq: TNGX), a clini

Tango Therapeutics rises 53% after early pancreatic cancer study data show strong response rates for

AAPL, SUNE, TNGX, APLD, CBRS were among the stocks seen trending on Monday, June 8, 2026.

Tango Therapeutics, Inc. (TNGX) Discusses Promising Clinical Results for Vopimetostat and Pan-RAS In

BOSTON, June 08, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (“Tango”) (Nasdaq: TNGX), a clini

Shares of Tango Therapeutics (TNGX) surged more than 51% on Monday after the clinical-stage biotechn

Tango Therapeutics stock soars after the biotech company announces initial data from its ongoing stu

US stocks rose with Nasdaq up 400 points. Dow up 0.32%, Nasdaq up 1.55%, S&P 500 up 0.94%. Tech

U.S. stocks were higher, with the Nasdaq Composite gaining around 1% on Monday.

U.S. stocks higher, Nasdaq Composite up 1%. Tango Therapeutics (TNGX) shares up 34.1% on positive tr

Tango Therapeutics said on Monday an experimental drug combination showed strong early results in a

Initial data from ongoing Phase 1/2 trial in patients with second and third line PDAC treated with v

BOSTON, June 05, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced t

This biotechnology firm advances targeted cancer therapies, leveraging genetic insights and strategi

US stocks down, S&P 500 falls 1%; Dow down 1.08%, NASDAQ down 1.42%. Energy shares up 1.5%; mate

Top analysts changed outlook on top names. See all rating changes on analyst ratings page. Check out

U.S. stock futures lower, Nasdaq down 1%. DeFi Technologies (DEFT) shares fell 5.3% after Q1 results

Figma Inc (NYSE: FIG) shares rose 10.6% in pre-market trading after beating Q1 revenue and earnings

Top analysts change outlook on top names: HC Wainwright & Co. cut FEAM price target, Bernstein d

  During Wednesday's session, 212 companies made new 52-week lows.

  During Tuesday's morning session, 137 companies made new 52-week lows.

  On Thursday, 1076 companies hit new 52-week lows.

  During Friday's session, 574 stocks hit new 52-week lows.

  On Tuesday, 951 companies hit new 52-week lows.

Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares surged 126% to close at $14.96 on

  During Monday's trading, 1214 companies set new 52-week lows.

  On Friday, 1043 companies hit new 52-week lows.

  Wednesday's session saw 784 companies set new 52-week lows.